Related references
Note: Only part of the references are listed.A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans
Frida Gustafsson et al.
TOXICOLOGICAL SCIENCES (2014)
HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved
Laia Tolosa et al.
ARCHIVES OF TOXICOLOGY (2013)
Protective effects of L-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin
Rute A. P. Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Mechanisms of the Statins Cytotoxicity in Freshly Isolated Rat Hepatocytes
Narges Abdoli et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2013)
A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays
James Hynes et al.
TOXICOLOGY IN VITRO (2013)
In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs
Richard A. Thompson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Jaundice Due to Suspected Statin Hepatotoxicity: A Case Series
Ottar M. Bergmann et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Central role of mitochondria in drug-induced liver injury
Dominique Pessayre et al.
DRUG METABOLISM REVIEWS (2012)
Mitochondria and cell signalling
Stephen W. G. Tait et al.
JOURNAL OF CELL SCIENCE (2012)
Implications of Altered Glutathione Metabolism in Aspirin-Induced Oxidative Stress and Mitochondrial Dysfunction in HepG2 Cells
Haider Raza et al.
PLOS ONE (2012)
Differential Mitochondrial Toxicity Screening and Multi-Parametric Data Analysis
Maria V. Tsiper et al.
PLOS ONE (2012)
Development of a Multiparametric Cell-based Protocol to Screen and Classify the Hepatotoxicity Potential of Drugs
Laia Tolosa et al.
TOXICOLOGICAL SCIENCES (2012)
Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity
Jae-Ah Kim et al.
TOXICOLOGY LETTERS (2012)
Cytometric Assessment of Mitochondria Using Fluorescent Probes
Cecile Cottet-Rousselle et al.
CYTOMETRY PART A (2011)
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
Karima Begriche et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Einar Björnsson et al.
JOURNAL OF HEPATOLOGY (2011)
Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells
Anke Van Summeren et al.
TOXICOLOGICAL SCIENCES (2011)
A high-throughput respirometric assay for mitochondrial biogenesis and toxicity
Craig C. Beeson et al.
ANALYTICAL BIOCHEMISTRY (2010)
Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells
Asuka Maeda et al.
ATHEROSCLEROSIS (2010)
Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells
N. Apostolova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity
Stefan Russmann et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
Silvia De la Iglesia Inigo et al.
LEUKEMIA RESEARCH (2009)
Drug-Induced Liver Injury Associated with Statins
Mark W. Russo et al.
SEMINARS IN LIVER DISEASE (2009)
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity
Benjamin D. Cosgrove et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells
Fozia Noor et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Adverse Effects of Statins - Mechanisms and Consequences
Jerzy Beltowski et al.
CURRENT DRUG SAFETY (2009)
Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Claudia V. Pereira et al.
CURRENT DRUG SAFETY (2009)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
New insights into mechanisms of statin-associated myotoxicity
Pascal Sirvent et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Multiparameter detection of apoptosis using red-excitable SYTO probes
Donald Wlodkowic et al.
CYTOMETRY PART A (2008)
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2008)
Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies
Gilles Labbe et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Medication-induced mitochondrial damage and disease
John Neustadt et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone
James A. Dykens et al.
TOXICOLOGICAL SCIENCES (2008)
Cellular imaging predictions of clinical drug-induced liver injury
Jinghai J. Xu et al.
TOXICOLOGICAL SCIENCES (2008)
Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration
Sashi Nadanaciva et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Automated laser scanning cytometry: A powerful tool for multi-parameter analysis of drug-induced apoptosis
Andrea Lisa Holme et al.
CYTOMETRY PART A (2007)
Drug-induced liver injury
Gebran Abboud et al.
DRUG SAFETY (2007)
Strategies to reduce late-stage drug attrition due to mitochondrial toxicity
James A. Dykens et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
The significance of mitochondrial toxicity testing in drug development
James A. Dykens et al.
DRUG DISCOVERY TODAY (2007)
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening
P. J. O'Brien et al.
ARCHIVES OF TOXICOLOGY (2006)
Mitochondria: More than just a powerhouse
Heidi M. McBride et al.
CURRENT BIOLOGY (2006)
An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics
L Vignati et al.
TOXICOLOGY (2005)
Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells.: II -: Mechanistic assays on NAD(P)H, ATP and DNA contents
WGEJ Schoonen et al.
TOXICOLOGY IN VITRO (2005)
Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells.: I -: Mechanistic assays on ROS, glutathione depletion and calcein uptake
WGEJ Schoonen et al.
TOXICOLOGY IN VITRO (2005)
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
JL Walgren et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Drug-associated mitochondrial toxicity and its detection
DE Amacher
CURRENT MEDICINAL CHEMISTRY (2005)
Safety of statins - Focus on clinical pharmacokinetics and drug interactions
S Bellosta et al.
CIRCULATION (2004)
MitoTracker Green labeling of mitochondrial proteins and their subsequent analysis by capillary electrophoresis with laser-induced fluorescence detection
AD Presley et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Medical progress: Drug-induced hepatotoxicity
WM Lee
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Sensitive markers used to identity compounds that trigger apoptosis in cultured hepatocytes
MJ Gómez-Lechón et al.
TOXICOLOGICAL SCIENCES (2002)
Share Paper
